DỮ LIỆU BÁO CÁO THƯỜNG NIÊN
CÁC CÔNG TY NIÊM YẾT NƯỚC NGOÀI

Báo cáo thường niên năm 2019 của Oxford Biomedica

Oxford BioMedica (LSE:OXB) is a leading gene and cell therapy company focused on developing life-changing treatments for serious diseases. Oxford BioMedica and its subsidiaries (the “Group”) have built a sector leading lentiviral vector delivery platform (LentiVector®) through which the Group develops in vivo and ex-vivo products both in-house and with partners. The Group has created a valuable proprietary portfolio of gene and cell therapy product candidates in the areas of oncology, ophthalmology and CNS disorders.

TÊN CÔNG TY / COMPANY
Oxford Biomedica

SÀN CHỨNG KHOÁN / STOCK EXCHANGE
LSE (England)

MÃ CHỨNG KHOÁN / TICKER
OXB

KỲ BÁO CÁO
2019

NGÀNH / INDUSTRY
Biotechnology

LĨNH VỰC / SECTOR
Healthcare